Biopharmaceutical CMO & CRO Market - Global Outlook and Forecast 2022-2028

March 2022 | 105 pages | ID: B9EAD0C38C09EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Biopharmaceutical CMO & CRO in Global, including the following market information:

Global Biopharmaceutical CMO & CRO Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biopharmaceutical CMO & CRO market was valued at 20680 million in 2021 and is projected to reach US$ 27600 million by 2028, at a CAGR of 4.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Biologics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biopharmaceutical CMO & CRO include Lonza, Boehringer Ingelheim GmbH, Rentschler Biotechnologie GmbH, Inno Biologics Sdn Bhd, JRS Pharma (Celonic GmbH), BIOMEVA GmbH, ProBioGen, FUJIFILM Diosynth Biotechnologies U.S.A., Inc. and TOYOBO CO., LTD, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biopharmaceutical CMO & CRO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biopharmaceutical CMO & CRO Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biopharmaceutical CMO & CRO Market Segment Percentages, by Type, 2021 (%)

• Biologics
• Biosimilars

Global Biopharmaceutical CMO & CRO Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biopharmaceutical CMO & CRO Market Segment Percentages, by Application, 2021 (%)

• Contract Manufacturing
• Contract Research

Global Biopharmaceutical CMO & CRO Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biopharmaceutical CMO & CRO Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biopharmaceutical CMO & CRO revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biopharmaceutical CMO & CRO revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Lonza
• Boehringer Ingelheim GmbH
• Rentschler Biotechnologie GmbH
• Inno Biologics Sdn Bhd
• JRS Pharma (Celonic GmbH)
• BIOMEVA GmbH
• ProBioGen
• FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
• TOYOBO CO., LTD
• Samsung BioLogics
• Patheon
• CMC Biologics
• Binex Co., Ltd.
• AbbVie Inc.
• WuXi Biologics.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Biopharmaceutical CMO & CRO Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Biopharmaceutical CMO & CRO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOPHARMACEUTICAL CMO & CRO OVERALL MARKET SIZE

2.1 Global Biopharmaceutical CMO & CRO Market Size: 2021 VS 2028
2.2 Global Biopharmaceutical CMO & CRO Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Biopharmaceutical CMO & CRO Players in Global Market
3.2 Top Global Biopharmaceutical CMO & CRO Companies Ranked by Revenue
3.3 Global Biopharmaceutical CMO & CRO Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceutical CMO & CRO Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biopharmaceutical CMO & CRO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceutical CMO & CRO Players in Global Market
  3.6.1 List of Global Tier 1 Biopharmaceutical CMO & CRO Companies
  3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceutical CMO & CRO Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Biopharmaceutical CMO & CRO Market Size Markets, 2021 & 2028
  4.1.2 Biologics
  4.1.3 Biosimilars
4.2 By Type - Global Biopharmaceutical CMO & CRO Revenue & Forecasts
  4.2.1 By Type - Global Biopharmaceutical CMO & CRO Revenue, 2017-2022
  4.2.2 By Type - Global Biopharmaceutical CMO & CRO Revenue, 2023-2028
  4.2.3 By Type - Global Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Biopharmaceutical CMO & CRO Market Size, 2021 & 2028
  5.1.2 Contract Manufacturing
  5.1.3 Contract Research
5.2 By Application - Global Biopharmaceutical CMO & CRO Revenue & Forecasts
  5.2.1 By Application - Global Biopharmaceutical CMO & CRO Revenue, 2017-2022
  5.2.2 By Application - Global Biopharmaceutical CMO & CRO Revenue, 2023-2028
  5.2.3 By Application - Global Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Biopharmaceutical CMO & CRO Market Size, 2021 & 2028
6.2 By Region - Global Biopharmaceutical CMO & CRO Revenue & Forecasts
  6.2.1 By Region - Global Biopharmaceutical CMO & CRO Revenue, 2017-2022
  6.2.2 By Region - Global Biopharmaceutical CMO & CRO Revenue, 2023-2028
  6.2.3 By Region - Global Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Biopharmaceutical CMO & CRO Revenue, 2017-2028
  6.3.2 US Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.3.3 Canada Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.3.4 Mexico Biopharmaceutical CMO & CRO Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Biopharmaceutical CMO & CRO Revenue, 2017-2028
  6.4.2 Germany Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.4.3 France Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.4.4 U.K. Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.4.5 Italy Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.4.6 Russia Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.4.7 Nordic Countries Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.4.8 Benelux Biopharmaceutical CMO & CRO Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Biopharmaceutical CMO & CRO Revenue, 2017-2028
  6.5.2 China Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.5.3 Japan Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.5.4 South Korea Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.5.5 Southeast Asia Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.5.6 India Biopharmaceutical CMO & CRO Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Biopharmaceutical CMO & CRO Revenue, 2017-2028
  6.6.2 Brazil Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.6.3 Argentina Biopharmaceutical CMO & CRO Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Biopharmaceutical CMO & CRO Revenue, 2017-2028
  6.7.2 Turkey Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.7.3 Israel Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.7.4 Saudi Arabia Biopharmaceutical CMO & CRO Market Size, 2017-2028
  6.7.5 UAE Biopharmaceutical CMO & CRO Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Lonza
  7.1.1 Lonza Corporate Summary
  7.1.2 Lonza Business Overview
  7.1.3 Lonza Biopharmaceutical CMO & CRO Major Product Offerings
  7.1.4 Lonza Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.1.5 Lonza Key News
7.2 Boehringer Ingelheim GmbH
  7.2.1 Boehringer Ingelheim GmbH Corporate Summary
  7.2.2 Boehringer Ingelheim GmbH Business Overview
  7.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Major Product Offerings
  7.2.4 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.2.5 Boehringer Ingelheim GmbH Key News
7.3 Rentschler Biotechnologie GmbH
  7.3.1 Rentschler Biotechnologie GmbH Corporate Summary
  7.3.2 Rentschler Biotechnologie GmbH Business Overview
  7.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Major Product Offerings
  7.3.4 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.3.5 Rentschler Biotechnologie GmbH Key News
7.4 Inno Biologics Sdn Bhd
  7.4.1 Inno Biologics Sdn Bhd Corporate Summary
  7.4.2 Inno Biologics Sdn Bhd Business Overview
  7.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Major Product Offerings
  7.4.4 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.4.5 Inno Biologics Sdn Bhd Key News
7.5 JRS Pharma (Celonic GmbH)
  7.5.1 JRS Pharma (Celonic GmbH) Corporate Summary
  7.5.2 JRS Pharma (Celonic GmbH) Business Overview
  7.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Major Product Offerings
  7.5.4 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.5.5 JRS Pharma (Celonic GmbH) Key News
7.6 BIOMEVA GmbH
  7.6.1 BIOMEVA GmbH Corporate Summary
  7.6.2 BIOMEVA GmbH Business Overview
  7.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Major Product Offerings
  7.6.4 BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.6.5 BIOMEVA GmbH Key News
7.7 ProBioGen
  7.7.1 ProBioGen Corporate Summary
  7.7.2 ProBioGen Business Overview
  7.7.3 ProBioGen Biopharmaceutical CMO & CRO Major Product Offerings
  7.7.4 ProBioGen Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.7.5 ProBioGen Key News
7.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  7.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Corporate Summary
  7.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
  7.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Major Product Offerings
  7.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Key News
7.9 TOYOBO CO., LTD
  7.9.1 TOYOBO CO., LTD Corporate Summary
  7.9.2 TOYOBO CO., LTD Business Overview
  7.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Major Product Offerings
  7.9.4 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.9.5 TOYOBO CO., LTD Key News
7.10 Samsung BioLogics
  7.10.1 Samsung BioLogics Corporate Summary
  7.10.2 Samsung BioLogics Business Overview
  7.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Major Product Offerings
  7.10.4 Samsung BioLogics Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.10.5 Samsung BioLogics Key News
7.11 Patheon
  7.11.1 Patheon Corporate Summary
  7.11.2 Patheon Business Overview
  7.11.3 Patheon Biopharmaceutical CMO & CRO Major Product Offerings
  7.11.4 Patheon Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.11.5 Patheon Key News
7.12 CMC Biologics
  7.12.1 CMC Biologics Corporate Summary
  7.12.2 CMC Biologics Business Overview
  7.12.3 CMC Biologics Biopharmaceutical CMO & CRO Major Product Offerings
  7.12.4 CMC Biologics Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.12.5 CMC Biologics Key News
7.13 Binex Co., Ltd.
  7.13.1 Binex Co., Ltd. Corporate Summary
  7.13.2 Binex Co., Ltd. Business Overview
  7.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Major Product Offerings
  7.13.4 Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.13.5 Binex Co., Ltd. Key News
7.14 AbbVie Inc.
  7.14.1 AbbVie Inc. Corporate Summary
  7.14.2 AbbVie Inc. Business Overview
  7.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Major Product Offerings
  7.14.4 AbbVie Inc. Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.14.5 AbbVie Inc. Key News
7.15 WuXi Biologics.
  7.15.1 WuXi Biologics. Corporate Summary
  7.15.2 WuXi Biologics. Business Overview
  7.15.3 WuXi Biologics. Biopharmaceutical CMO & CRO Major Product Offerings
  7.15.4 WuXi Biologics. Biopharmaceutical CMO & CRO Revenue in Global Market (2017-2022)
  7.15.5 WuXi Biologics. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Biopharmaceutical CMO & CRO Market Opportunities & Trends in Global Market
Table 2. Biopharmaceutical CMO & CRO Market Drivers in Global Market
Table 3. Biopharmaceutical CMO & CRO Market Restraints in Global Market
Table 4. Key Players of Biopharmaceutical CMO & CRO in Global Market
Table 5. Top Biopharmaceutical CMO & CRO Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biopharmaceutical CMO & CRO Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biopharmaceutical CMO & CRO Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biopharmaceutical CMO & CRO Product Type
Table 9. List of Global Tier 1 Biopharmaceutical CMO & CRO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceutical CMO & CRO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biopharmaceutical CMO & CRO Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biopharmaceutical CMO & CRO Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biopharmaceutical CMO & CRO Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biopharmaceutical CMO & CRO Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biopharmaceutical CMO & CRO Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biopharmaceutical CMO & CRO Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2023-2028
Table 30. Lonza Corporate Summary
Table 31. Lonza Biopharmaceutical CMO & CRO Product Offerings
Table 32. Lonza Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 33. Boehringer Ingelheim GmbH Corporate Summary
Table 34. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Offerings
Table 35. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 36. Rentschler Biotechnologie GmbH Corporate Summary
Table 37. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Offerings
Table 38. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 39. Inno Biologics Sdn Bhd Corporate Summary
Table 40. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Offerings
Table 41. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 42. JRS Pharma (Celonic GmbH) Corporate Summary
Table 43. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Product Offerings
Table 44. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 45. BIOMEVA GmbH Corporate Summary
Table 46. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Offerings
Table 47. BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 48. ProBioGen Corporate Summary
Table 49. ProBioGen Biopharmaceutical CMO & CRO Product Offerings
Table 50. ProBioGen Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 51. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Corporate Summary
Table 52. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Product Offerings
Table 53. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 54. TOYOBO CO., LTD Corporate Summary
Table 55. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product Offerings
Table 56. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 57. Samsung BioLogics Corporate Summary
Table 58. Samsung BioLogics Biopharmaceutical CMO & CRO Product Offerings
Table 59. Samsung BioLogics Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 60. Patheon Corporate Summary
Table 61. Patheon Biopharmaceutical CMO & CRO Product Offerings
Table 62. Patheon Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 63. CMC Biologics Corporate Summary
Table 64. CMC Biologics Biopharmaceutical CMO & CRO Product Offerings
Table 65. CMC Biologics Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 66. Binex Co., Ltd. Corporate Summary
Table 67. Binex Co., Ltd. Biopharmaceutical CMO & CRO Product Offerings
Table 68. Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 69. AbbVie Inc. Corporate Summary
Table 70. AbbVie Inc. Biopharmaceutical CMO & CRO Product Offerings
Table 71. AbbVie Inc. Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)
Table 72. WuXi Biologics. Corporate Summary
Table 73. WuXi Biologics. Biopharmaceutical CMO & CRO Product Offerings
Table 74. WuXi Biologics. Biopharmaceutical CMO & CRO Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Biopharmaceutical CMO & CRO Segment by Type in 2021
Figure 2. Biopharmaceutical CMO & CRO Segment by Application in 2021
Figure 3. Global Biopharmaceutical CMO & CRO Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biopharmaceutical CMO & CRO Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biopharmaceutical CMO & CRO Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biopharmaceutical CMO & CRO Revenue in 2021
Figure 8. By Type - Global Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
Figure 12. US Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
Figure 16. Germany Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 17. France Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
Figure 24. China Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 28. India Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
Figure 30. Brazil Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biopharmaceutical CMO & CRO Revenue Market Share, 2017-2028
Figure 33. Turkey Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biopharmaceutical CMO & CRO Revenue, (US$, Mn), 2017-2028
Figure 37. Lonza Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ProBioGen Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Samsung BioLogics Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Patheon Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. CMC Biologics Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. AbbVie Inc. Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. WuXi Biologics. Biopharmaceutical CMO & CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)